These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7085534

  • 1. Chemoprophylaxis of experimental endocarditis caused by Staphylococcus aureus.
    Dhawan VK, Thadepalli H, Rao B, Kannangara DW, Mandal AK.
    J Antimicrob Chemother; 1982 Apr; 9(4):319-24. PubMed ID: 7085534
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 3. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ.
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [Abstract] [Full Text] [Related]

  • 4. Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Cefazolin in Prime But Nafcillin Not Ready for an Exit.
    Sarria JC.
    Am J Med Sci; 2020 Jul; 360(1):3-4. PubMed ID: 32439151
    [No Abstract] [Full Text] [Related]

  • 5. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Archer GL, Vazquez GJ, Johnston JL.
    J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687
    [Abstract] [Full Text] [Related]

  • 6. Antibiotic prophylaxis against bacterial endocarditis in patients undergoing dermatologic surgery.
    Wagner RF, Grande DJ, Feingold DS.
    Arch Dermatol; 1986 Jul; 122(7):799-801. PubMed ID: 3729511
    [No Abstract] [Full Text] [Related]

  • 7. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA, Courtney KB.
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [Abstract] [Full Text] [Related]

  • 8. Clindamycin therapy of experimental Staphylococcus aureus endocarditis.
    Scheld WM, Johnson ML, Gerhardt EB, Sande MA.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):646-9. PubMed ID: 7081981
    [Abstract] [Full Text] [Related]

  • 9. Cefazolin therapy for Staphylococcus aureus bacteremia.
    Fernández-Guerrero ML, de Górgolas M.
    Clin Infect Dis; 2005 Jul 01; 41(1):127. PubMed ID: 15937778
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
    Dhawan VK, Maier MK, Nayyar M, Chuah SK, Thadepalli H.
    Chemotherapy; 1984 Jul 01; 30(5):328-30. PubMed ID: 6092007
    [Abstract] [Full Text] [Related]

  • 11. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
    Pollett S, Baxi SM, Rutherford GW, Doernberg SB, Bacchetti P, Chambers HF.
    Antimicrob Agents Chemother; 2016 Aug 01; 60(8):4684-9. PubMed ID: 27216053
    [Abstract] [Full Text] [Related]

  • 12. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
    Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB, Korea INfectious Diseases (KIND) study group.
    Clin Microbiol Infect; 2018 Feb 01; 24(2):152-158. PubMed ID: 28694202
    [Abstract] [Full Text] [Related]

  • 13. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.
    Nannini EC, Singh KV, Murray BE.
    Clin Infect Dis; 2003 Nov 01; 37(9):1194-8. PubMed ID: 14557964
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin-Preliminary report.
    Casalta JP, Zaratzian C, Hubert S, Thuny F, Gouriet F, Habib G, Grisoli D, Deharo JC, Raoult D.
    Int J Antimicrob Agents; 2013 Aug 01; 42(2):190-1. PubMed ID: 23796892
    [No Abstract] [Full Text] [Related]

  • 15. Methicillin-resistant Staphylococcus aureus: a community concern.
    Hedge DD.
    S D Med; 2006 Oct 01; 59(10):433, 435. PubMed ID: 17124921
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotic prophylaxis in cardiac surgery.
    Wilson AP.
    J Antimicrob Chemother; 1988 May 01; 21(5):522-4. PubMed ID: 3292496
    [No Abstract] [Full Text] [Related]

  • 17. Antibiotic prophylaxis against infective endocarditis after delivery.
    Fleming HA.
    Lancet; 1977 Jan 15; 1(8003):144-5. PubMed ID: 64677
    [No Abstract] [Full Text] [Related]

  • 18. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis.
    Archer GL, Armstrong BC.
    J Infect Dis; 1983 Apr 15; 147(4):642-9. PubMed ID: 6601682
    [Abstract] [Full Text] [Related]

  • 19. Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
    Carrizosa J, Kobasa WD, Snepar R, Kaye KM, Kaye D.
    J Antimicrob Chemother; 1982 May 15; 9(5):387-93. PubMed ID: 6980218
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    Sande MA, Johnson ML.
    J Infect Dis; 1975 Apr 15; 131(4):367-75. PubMed ID: 1117194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.